Author(s): Chowdhury N
Abstract Share this page
India has become a hotbed of clinical trials, but recent reports of safety lapses have prompted calls for better regulation in this area. Currently, trial requirements can be relaxed if doing so is in the 'public interest', but a clearer definition of what this means is needed before this provision should be used.
This article was published in Nat Med
and referenced in Journal of Clinical Research & Bioethics